GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CRISPR Therapeutics AG (MEX:CRSP) » Definitions » Cyclically Adjusted Book per Share

CRISPR Therapeutics AG (MEX:CRSP) Cyclically Adjusted Book per Share : MXN0.00 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is CRISPR Therapeutics AG Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CRISPR Therapeutics AG's adjusted book value per share for the three months ended in Mar. 2025 was MXN435.440. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN0.00 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-12), CRISPR Therapeutics AG's current stock price is MXN737.00. CRISPR Therapeutics AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was MXN0.00. CRISPR Therapeutics AG's Cyclically Adjusted PB Ratio of today is .

During the past 11 years, the highest Cyclically Adjusted PB Ratio of CRISPR Therapeutics AG was 2.41. The lowest was 2.00. And the median was 2.33.


CRISPR Therapeutics AG Cyclically Adjusted Book per Share Historical Data

The historical data trend for CRISPR Therapeutics AG's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRISPR Therapeutics AG Cyclically Adjusted Book per Share Chart

CRISPR Therapeutics AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CRISPR Therapeutics AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CRISPR Therapeutics AG's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, CRISPR Therapeutics AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CRISPR Therapeutics AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CRISPR Therapeutics AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CRISPR Therapeutics AG's Cyclically Adjusted PB Ratio falls into.


;
;

CRISPR Therapeutics AG Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CRISPR Therapeutics AG's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=435.44/107.7224*107.7224
=435.440

Current CPI (Mar. 2025) = 107.7224.

CRISPR Therapeutics AG Quarterly Data

Book Value per Share CPI Adj_Book
201412 -3.583 100.704 -3.833
201509 0.000 99.785 0.000
201512 -17.077 99.386 -18.509
201603 0.000 99.475 0.000
201606 62.970 100.088 67.773
201609 -30.394 99.604 -32.871
201612 120.864 99.380 131.011
201703 101.764 100.040 109.579
201706 89.300 100.285 95.923
201709 79.424 100.254 85.341
201712 90.878 100.213 97.688
201803 112.994 100.836 120.711
201806 110.685 101.435 117.546
201809 151.411 101.246 161.097
201812 148.511 100.906 158.543
201903 139.972 101.571 148.449
201906 132.017 102.044 139.363
201909 211.724 101.396 224.935
201912 291.484 101.063 310.690
202003 341.225 101.048 363.765
202006 328.204 100.743 350.941
202009 420.300 100.585 450.126
202012 447.879 100.241 481.308
202103 487.333 100.800 520.801
202106 681.290 101.352 724.111
202109 675.761 101.533 716.959
202112 639.337 101.776 676.694
202203 577.605 103.205 602.887
202206 540.715 104.783 555.884
202209 502.298 104.835 516.133
202212 465.717 104.666 479.316
202303 423.951 106.245 429.848
202306 392.252 106.576 396.473
202309 378.917 106.570 383.016
202312 399.270 106.461 404.000
202403 407.666 107.355 409.062
202406 426.724 107.991 425.663
202409 447.554 107.468 448.614
202412 469.955 107.128 472.562
202503 435.440 107.722 435.440

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


CRISPR Therapeutics AG  (MEX:CRSP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of CRISPR Therapeutics AG was 2.41. The lowest was 2.00. And the median was 2.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CRISPR Therapeutics AG Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of CRISPR Therapeutics AG's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CRISPR Therapeutics AG Business Description

Industry
Traded in Other Exchanges
Address
Baarerstrasse 14, Zug, CHE, CH-6300
Crispr Therapeutics AG is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.